Scientists are increasingly finding that the gastrointestinal (GI) tract plays a vital role in our overall health. While its main functions center around digestion, the GI tract is also involved in the production of hormones, immune cells, and even neurotransmitters that can affect mood and brain function. As such, the GI tract is host to many different biomarkers that can be useful for identifying, monitoring, and treating disease-everything from short-chain fatty acids that are indicators of metabolic syndrome to cytokines that are biomarkers of inflammation.
But there is no technology currently available that can easily profile this metabolic, molecular information from the GI tract. Traditional evaluation methods involve either fecal analysis or biopsy, which are invasive, expensive, and cannot provide real-time profiling across the GI tract.
Now a team of Caltech engineers has developed a smart capsule called PillTrek, which can measure pH, temperature, and a variety of different biomarkers. It incorporates simple, inexpensive sensors in a miniature wireless electrochemical workstation that relies on low-power electronics. PillTrek is tiny, measuring 7 millimeters in diameter and 25 millimeters in length, making it smaller than commercially available capsule cameras used for endoscopy but capable of executing a range of electrochemical measurements.
"We designed this pill to be a very versatile platform," says Wei Gao , professor of medical engineering at Caltech and a Heritage Medical Research Institute Investigator. "From an electrochemical-sensing point of view, it is very powerful. It has the ability to measure metabolites, ions, hormones such as serotonin and dopamine, possibly even proteins as well. And all within the gut, which is a complex environment."
The scientists describe the capsule in a new paper in the journal Nature Electronics. The lead authors of the paper are Jihong Min, a postdoctoral scholar fellowship trainee in medical engineering at Caltech, and Hyunah Ahn, a visitor in medical engineering at Caltech and graduate student at the Korea Advanced Institute of Science and Technology (KAIST).
As a proof of concept, PillTrek was used in the study to measure pH and temperature as well as changing levels of glucose and the neurotransmitter serotonin in animal models.
Gao points out that the electrochemical workstation within the capsule is reconfigurable. A variety of different sensors could easily be swapped into place to enable measurements of different parameters in the gut. His team previously developed a technique for 3D printing inexpensive sensors on sheets of plastic substrate. That technique can be used to mass-produce the sensors for PillTrek.
In terms of next steps, Gao says that he is working with co-author Azita Emami, the Andrew and Peggy Cherng Professor of Electrical Engineering and Medical Engineering at Caltech and director of the Center for Sensing to Intelligence, to look into wireless power transfer and smaller electronics that would make PillTrek even smaller and lower power.
Additional authors of the paper are Heather Lukas (MS '21), Xiaotian Ma, Rinni Bhansali, Sung-Hyuk Sunwoo, Canran Wang (MS '23), Yadong Xu, Dickson R. Yao, and Gwangmook Kim of Caltech, as well as Zhaoping Li and Tzung K. Hsiai of the David Geffen School of Medicine at UCLA and Hee-Tae Jung of KAIST.
The work was supported by funding from the National Science Foundation, the National Institutes of Health, the American Cancer Society, the Army Research Office, the US Army Medical Research Acquisition Activity, the National Research Foundation of Korea, the Heritage Medical Research Institute, and the KAIST-UC Berkeley-VNU Global Climate Change Research Center. The team also received critical support and infrastructure from the Kavli Nanoscience Institute at Caltech.
